Analyze the companies that are moving assertively toward International Financial Reporting Standards (IFRS), and you’ll note several predominant characteristics. Most have global operations, complex organizational structures, and aggressive competition. They are often publicly held. And they frequently are known for innovation and leadership. In other words, they sound a lot like a global life sciences company. This publication "IFRS in the Life Sciences: Broad Implications" provides practical industry insights on IFRS for life science executives and includes useful sections on: IFRS challenges and opportunities in life sciences; Implications of IFRS for financial reporting, tax, human resources, mergers and acquisitions, IT, and treasury; Key actions steps for life science executives; Approaches to IFRS conversion; Key differences between IFRS and U.S. Generally Accepted Accounting Principles (GAAP) for the life science industry.